Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP788101.RA9K1kgLC5UGnSk7h6iePmB3-jmXQfPmeNXzWwAkxdYQE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP788101.RA9K1kgLC5UGnSk7h6iePmB3-jmXQfPmeNXzWwAkxdYQE130_assertion type Assertion NP788101.RA9K1kgLC5UGnSk7h6iePmB3-jmXQfPmeNXzWwAkxdYQE130_head.
- NP788101.RA9K1kgLC5UGnSk7h6iePmB3-jmXQfPmeNXzWwAkxdYQE130_assertion wasGeneratedBy ECO_0000203 NP788101.RA9K1kgLC5UGnSk7h6iePmB3-jmXQfPmeNXzWwAkxdYQE130_provenance.
- NP788101.RA9K1kgLC5UGnSk7h6iePmB3-jmXQfPmeNXzWwAkxdYQE130_assertion wasDerivedFrom befree-2016 NP788101.RA9K1kgLC5UGnSk7h6iePmB3-jmXQfPmeNXzWwAkxdYQE130_provenance.
- NP788101.RA9K1kgLC5UGnSk7h6iePmB3-jmXQfPmeNXzWwAkxdYQE130_assertion SIO_000772 20085575 NP788101.RA9K1kgLC5UGnSk7h6iePmB3-jmXQfPmeNXzWwAkxdYQE130_provenance.
- NP788101.RA9K1kgLC5UGnSk7h6iePmB3-jmXQfPmeNXzWwAkxdYQE130_assertion evidence source_evidence_literature NP788101.RA9K1kgLC5UGnSk7h6iePmB3-jmXQfPmeNXzWwAkxdYQE130_provenance.
- NP788101.RA9K1kgLC5UGnSk7h6iePmB3-jmXQfPmeNXzWwAkxdYQE130_assertion description "[Our data suggest that an intensive therapy regimen including stem cell transplantation may be favourable for bilineal or lineage switch cases, whereas patients with ETV6/RUNX1 fusion, lymphoid morphology and patients with expression of cyCD22 and cyCD79a should be treated with an ALL-directed therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP788101.RA9K1kgLC5UGnSk7h6iePmB3-jmXQfPmeNXzWwAkxdYQE130_provenance.